Comparative clinical trial of efficacy and satisfaction of 2% gel lidocaine versus tetracaine/oxybuprocaine anesthetic eye drops in patients undergoing needing techniques in ophthalmology consultations. Anesthesia in Needling with Lidocaine (ANELI)

Status

Suspended

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505131-13-01

Acronym

ANELI 003

Enrollment

Registered

2023-12-04

Start date

2024-01-11

Completion date

Unknown

Last updated

2023-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

Pain: Numerical rating scale (NRS) from 0 to 10, Surgeon comfort/degree of patient cooperation: numerical rating scale (NRS) from 0 to 10

Detailed description

Demographic variables: sex, age, Number of tetracaine booster drops, Need for oral analgesia: analgesic and dose used, Ocular surface condition: Measured according to the Oxford Scale from 0 to 5., Security: number of intra and post needling complications, IOP: Intraocular pressure in mmHg measured by Goldmann applanation tonometry., Absolute success: Number of patients (and percentage) controlled without antihypertensive therapy at 3 months Relative success: Number of patients controlled (and percentage) on hypotensive therapy at 3 months.

Interventions

DRUGOphtesic 20 mg/g

DRUGgel oftálmico en envase unidosis

DRUGCOLIROFTA ANESTÉSICO DOBLE 1 MG/ML + 4 MG/ML COLIRIO EN SOLUCIÓN

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Pain: Numerical rating scale (NRS) from 0 to 10, Surgeon comfort/degree of patient cooperation: numerical rating scale (NRS) from 0 to 10	—

Secondary

Measure	Time frame
Demographic variables: sex, age, Number of tetracaine booster drops, Need for oral analgesia: analgesic and dose used, Ocular surface condition: Measured according to the Oxford Scale from 0 to 5., Security: number of intra and post needling complications, IOP: Intraocular pressure in mmHg measured by Goldmann applanation tonometry., Absolute success: Number of patients (and percentage) controlled without antihypertensive therapy at 3 months Relative success: Number of patients controlled (and percentage) on hypotensive therapy at 3 months.	—

Measure

Time frame

—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026